Sony logo

CORPORATE SESSION


Enabling Standardization and Scale-up in Treg and other Next Generation Cell Therapies

Wednesday May 6, 2025
12:00 – 1:00 PM IST
Liffey Hall 2, Level 1

Chair/Moderator:

Cheryl Cox , Ph.D
Operations Director of Cell Therapies & Gene Engineering Facility
Moffitt Cancer Center, Florida, USA

Speakers:

Barabara Ressler, Ph.D
VP of Manufacturing Process Sciences
RoslinCT, Boston, USA

Kate Fynes, Ph.D
Senior CMC Translation Consultant
Exmoor Pharma, Bristol, U.K.

Manel Juan MD, Ph.D (or lab member)
Centro de Díagnóstico Biomédico
University Hospital Barcelona, Spain

Natalia Trzonkowska, Ph.D
Professor, International Centre for Cancer Vaccine Science
University of Gdańsk, Gdańsk, Poland

Sophie Blondel, Ph.D
Founder and CEO, FoxBio
Paris, France

NEXT-GENERATION CELL THERAPY ENABLEMENT

The CGX10 Cell Isolation System has been developed with the goal of enabling multi-marker selection to isolate target cells while ensuring high cell viability. The system delivers a user experience that is suited to the GMP compliant, cell production environment, and transcends the complexity and subjectivity of conventional sorter platforms.

LEARN MORE